Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Synlogic, Inc.
Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 09, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaboration
November 07, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Closing of $21.0 Million Underwritten Public Offering
October 03, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Pricing of $21.0 Million Underwritten Public Offering
September 29, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Publication of Synpheny-1 Phase 2 Study of Synthetic Biotic for Phenylketonuria in Nature Metabolism
September 28, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Reverse Stock Split
September 27, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic to Participate in Chardan’s Genetic Medicines Conference
September 21, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces CEO Aoife Brennan Named to PharmaVoice 100
September 19, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Granted Fast Track Designation from FDA for labafenogene marselecobac (SYNB1934) for Treatment of Phenylketonuria
July 11, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces International Nonproprietary Name Selection for SYNB1934
June 28, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Participation in SVB Securities Healthcare Therapeutics Forum
June 27, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Reminds Stockholders of 2023 Annual General Meeting Details
June 08, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria
June 05, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Data Presentations at the 2023 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference
May 24, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic to Present at the Jefferies Global Healthcare Conference
May 23, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Reports First Quarter 2023 Financial Results and Provides Business Update
May 11, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Receives Orphan Drug Designation from FDA for SYNB1934 for Treatment of Phenylketonuria
May 09, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates
March 29, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Receives Positive Opinion on Orphan Designation from the European Medicines Agency for SYNB1934 for the Treatment of Phenylketonuria
March 28, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
March 20, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 08, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic To Present Three Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
March 07, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Participation in Upcoming Investor and Industry Conferences
January 24, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Receives Rare Pediatric Disease Designation from FDA for SYNB1934 for Phenylketonuria (PKU)
January 19, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Provides Corporate Update and Outlook for 2023
January 05, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Appointment of Dr. Dave Hava as Head of Research and Development
January 03, 2023
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces Achievement of Proof of Concept for SYNB8802 in Enteric Hyperoxaluria Based on Urinary Oxalate Lowering in Phase 1b Study
December 15, 2022
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Announces SYNB1353 Achieves Proof of Mechanism for Treatment of Homocystinuria and Provides Business Update
November 30, 2022
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Synlogic Reports Third Quarter 2022 Financial Results and Provides Business Update
November 10, 2022
From
Synlogic, Inc.
Via
GlobeNewswire
Tickers
SYBX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.